Dr. Khaled Allemailem| Vaccine Development|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Khaled Allemailem,Vaccine Developmen,Best Researcher Award

Dr. ANTHOULA LAZARIS, at Qassim University,Saudi Arabia

PROFILE

scopus

Orcid

Google scholar

📚Early Academic Pursuits :

Khaled Saleh A. Allemailem began his academic journey at King Saud University, Qassim Branch, where he obtained a Bachelor’s degree in Medical Microbiology from 1998 to 2002. His passion for medical sciences led him to pursue advanced studies at RMIT University in Australia. He earned his Master of Laboratory Medicine from the School of Medical Sciences in July 2010 and subsequently completed a Graduate Diploma in Biotechnology from the School of Applied Sciences in December 2010. Khaled furthered his expertise by attaining a PhD in Microbiology from RMIT University in August 2016, with his thesis titled “Colonisation and Virulence Characteristics of Campylobacter concisus Oral and Clinical Strains.”

💼Professional Endeavors :

Khaled’s professional journey is marked by diverse roles in both academic and medical settings. He commenced his career as a teacher in the Ministry of Education, Saudi Arabia, from July 2003 to May 2007. He then transitioned to Qassim University, where he served as a Teaching Assistant in the Department of Medical Laboratories from May 2007 to February 2013. His dedication to education and research led to his promotion as a Lecturer in February 2013, and subsequently as an Assistant Professor in December 2016. In June 2021, Khaled was appointed Associate Professor, a position he currently holds. His teaching portfolio includes courses such as Clinical Bacteriology, Applied Microbiology, Research Methodology, and Medical Terminology.

🔬Contributions and Research Focus :

Khaled’s research primarily revolves around microbiology, with a specific focus on bacterial colonization, virulence, and antibiotic resistance. His doctoral thesis investigated the colonization and virulence characteristics of Campylobacter concisus, contributing valuable insights to the field. His hands-on expertise in PCR, SDS-PAGE, cloning, bacterial isolation, and characterization is complemented by proficiency in software like Clone Manager, MacVector, and Prism. Khaled has supervised master’s theses on topics such as the biogenic synthesis and antibacterial activity of zinc oxide nanoparticles and the prevalence and phylogenetic analysis of antibiotic-resistant bacterial isolates.

🏅Accolades and Recognition :

Throughout his career, Khaled has been recognized for his significant contributions to microbiology and medical education. His registration as a Consultant in Medical Microbiology by the Saudi Commission for Health Specialties (SCHS) is a testament to his expertise and professional standing. His work has not only advanced scientific understanding but also had a practical impact on healthcare practices, particularly in combating antibiotic resistance.

🌍Impact and Influence :

Khaled’s influence extends beyond his research contributions. As an educator, he has shaped the academic journeys of numerous students at Qassim University. His involvement in teaching both undergraduate and postgraduate courses has been instrumental in nurturing the next generation of medical laboratory scientists. Khaled’s commitment to student supervision, exemplified by his guidance of master’s students, underscores his dedication to academic mentorship and research excellence.

🌟Legacy and Future Contributions :

Khaled Saleh A. Allemailem’s legacy is characterized by his dual impact as a researcher and educator. His work in microbiology has contributed to the global understanding of bacterial colonization and antibiotic resistance, while his role as a professor has enriched the academic fabric of Qassim University. Looking ahead, Khaled is poised to continue his contributions to the field through ongoing research, student mentorship, and collaborative projects. His vision for the future includes expanding his research on microbial pathogenesis and exploring innovative solutions to emerging challenges in medical microbiology.

🎓Publication 

Implications of green tea and its constituents in the prevention of cancer via the modulation of cell signalling pathway

  • Authors   :Arshad H Rahmani, Fahad M Al Shabrmi, Khaled S Allemailem, Salah M Aly, Masood A Khan
  • Journal    :BioMed Research International
  • Year         :2015

The biochemical and clinical perspectives of lactate dehydrogenase: an enzyme of active metabolism

    • Authors :Amjad A Khan, Khaled S Allemailem, Fahad A Alhumaydhi, Sivakumar JT Gowder, Arshad H Rahmani
    • Journal   :Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)
    • Year       : 2020

Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways

  • Authors  :,Saleh A Almatroodi, Mohammed A Alsahli, Ahmad Almatroudi, Amit Kumar Verma, Abdulaziz Aloliqi, Khaled S Allemailem, Amjad Ali Khan, Arshad Husain Rahmani
  • Journal    :Molecules
  • Year         :  2021

Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications

  • Authors  :Amjad Ali Khan, Khaled S Allemailem, Saleh A Almatroodi, Ahmed Almatroudi, Arshad Husain Rahmani
  • Journal   :3 Biotech
  • Year        :   2020

Bioinspired Green Synthesis of Zinc Oxide Nanoparticles from a Native Bacillus cereus Strain RNT6: Characterization and Antibacterial Activity against Rice Panicle Blight Pathogens …

  • Authors  :Rada, M., Krzywon, L., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Nanomaterials
  • Year        :  2021

Dr. ANTHOULA LAZARIS| Precision Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Dr. ANTHOULA LAZARIS, Precision Medicine,Best Researcher Award

Dr. ANTHOULA LAZARIS, at MCGILL UNIV. HEALTH CTR,Canada

PROFILE

scopus

📚 Early Academic Pursuits :

Anthoula Lazaris began her academic journey with a B.Sc. in Microbiology and Immunology from McGill University (1983-1986), where she developed a solid foundation in the biological sciences. She continued at McGill, earning a Ph.D. in Biochemistry from the Faculty of Medicine (1988-1992). Her postdoctoral studies took her to Leiden, The Netherlands, where she further honed her expertise in Medical Biochemistry (1992-1994). This robust educational background laid the groundwork for her illustrious career in academia and biotechnology.

🏢Professional Endeavors :

Lazaris has accumulated over 30 years of combined experience in academia and industry, holding management and senior-level positions. Currently, she is a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), focusing on metastatic and metabolic diseases with an emphasis on translational research. Her career highlights include:

  • Liver Disease Biobank: In 2011, Lazaris established a Liver Disease Biobank in collaboration with Dr. P Metrakos, collecting biospecimens from patients with liver-related diseases.
  • Quebec Extracellular Vesicle Consortium: She spearheaded this consortium with Drs. Rak and Olivier, demonstrating her leadership in collaborative research initiatives.
  • CIHR Training Grant: Lazaris co-wrote and secured a substantial CIHR training grant for the Goodman Cancer Centre, illustrating her proficiency in obtaining competitive funding.

🔬Contributions and Research Focus :

Lazaris’s research contributions span several critical areas:

  • Metastatic Disease: She focuses on colorectal cancer liver metastases (CRCLM), investigating molecular mechanisms to predict therapeutic responses and developing new biomarkers.
  • Translational Research: Her work bridges basic and clinical research, aiming to translate findings into precision therapies for cancer patients. Notably, her research on predictors of therapeutic responses to antiangiogenic agents has been groundbreaking.
  • Liver Diseases: Lazaris’s research also covers hepatocellular carcinoma, cholangiocarcinomas, and NAFLD/NASH, contributing to the broader understanding of these conditions.

🏆Accolades and Recognition :

Throughout her career, Lazaris has received numerous accolades:

  • Scientific American Award: In 2002, she was recognized in the category of Research Leader in Chemical and Materials for her work on transgenic animals producing spider silk.
  • Genome Canada White Paper: She spearheaded the writing of a white paper on “Disease Mechanisms,” which was integrated into Genome Quebec’s strategic plan.
  • Scientific Publications: Her research has been published in prestigious journals like Nature and Science, highlighting her contributions to molecular biology and oncology.

🌍Impact and Influence :

Lazaris’s work has had a profound impact on both the scientific community and public health:

  • Innovations in Biotechnology: She was part of the team that demonstrated the first expression of soluble spider silk, which can be spun into fibers with remarkable mechanical properties.
  • Transgenic Research Network: As the Executive Director of the Quebec Transgenic Research Network, Lazaris unified the capabilities of researchers across Quebec, securing significant funding and fostering collaborative research.
  • Cloned Animals: She was part of the team that generated the world’s first cloned goat and Canada’s first large transgenic animal, showcasing her pioneering contributions to genetic engineering.

🌟Legacy and Future Contributions :

Anthoula Lazaris’s legacy is marked by her pioneering research, leadership in collaborative scientific endeavors, and significant contributions to translational medicine. Her work continues to influence the fields of molecular biology, biotechnology, and cancer research. Looking forward, Lazaris is expected to further her contributions to personalized medicine, leveraging her extensive experience and innovative approach to address pressing challenges in healthcare. Her dedication to translational research and collaborative spirit ensures that her impact will be felt for years to come.

🎓Publication 

Predictive biomarker discovery in cancer using a unique AI model based on set theory

Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 – β-catenin cascade to promote liver tumorigenesis

    • Authors :Sinha, S., Aizawa, S., Nakano, Y., … Guccione, E., Tsukamoto, H.
    • Journal   :Nature Communications
    • Year       : 2023

Targeting Liver Metastases to Potentiate Immunotherapy in MS-Stable Colorectal Cancer—A Review of the Literature

  • Authors  :, Zlotnik, O., Krzywon, L., Bloom, J., … Lazaris, A., Metrakos, P.
  • Journal    :Cancers
  • Year         :  2023

Isolation of extracellular vesicles from human plasma samples: The importance of controls

  • Authors  :Tsamchoe, M., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Biotechnology Journal
  • Year        :   2023

A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases

  • Authors  :Rada, M., Krzywon, L., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Biotechnology 
  • Year        :  2023

Ms. Ara Cho| Biomarker Research|Best Researcher Award

Published on by Top Pharmaceutical

Ms. Ara Cho, Biomarker Research,Best Researcher Award

Ms. Ara Cho, at Seoul National University,South Korea

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Ara Cho embarked on her academic journey at The Catholic University of Korea, where she pursued a Bachelor’s degree in Biology from the Department of Life Science and Environment. From March 2015 to February 2019, she dedicated herself to understanding the fundamental principles of biology, earning a B.S. in Biology with commendable academic performance. Her undergraduate years were marked by a growing interest in analytical chemistry and proteomics, which set the stage for her future research endeavors.

In September 2019, Ara Cho continued her academic pursuits at Seoul National University, enrolling in the Ph.D. program in the Department of Molecular Medicine and Biopharmaceutical Sciences. Her rigorous coursework and research in this program have been driven by a profound interest in mass spectrometry-based proteomics and translational bioinformatics. Maintaining an impressive GPA of 4.1/4.3, Ara has demonstrated exceptional academic prowess and a commitment to advancing scientific knowledge.

👩‍🔬Professional Endeavors :

Ara Cho’s professional journey is distinguished by a series of impactful research experiences and collaborations. She served as a research intern at the Graduate School of Convergence Science and Technology at Seoul National University from January 2018 to December 2018. This experience honed her skills in proteomics and data analysis, providing a solid foundation for her future research projects.

Subsequently, she continued as a research intern at the Department of Molecular Medicine and Biopharmaceutical Sciences at Seoul National University from March 2019 to August 2019. Her internship experiences allowed her to work on cutting-edge research projects, further deepening her expertise in proteomics and biomarker discovery.

From November 2022 to April 2023, Ara expanded her research horizons internationally as a researcher at the Fred Hutchinson Cancer Research Center in Seattle, United States. This position enabled her to collaborate with leading scientists and gain exposure to advanced research methodologies and technologies, significantly enriching her research portfolio.

🔬Contributions and Research Focus :

Ara Cho’s research is characterized by its focus on analytical chemistry, mass spectrometry-based proteomics, data analysis, machine learning, and translational bioinformatics. Her work aims to develop innovative biomarker panels and diagnostic strategies to improve disease prediction and treatment outcomes. Notable among her contributions are her publications in high-impact journals and her involvement in significant research projects.

Her research publications include:

  1. Proteomics Analysis of FFPE Tissue Sections: This study, published in Rapid Communications in Mass Spectrometry (2023), highlights Ara’s expertise in proteomics and her innovative use of isobaric-tag amplification for individual tissue sections.
  2. Multi-Biomarker Panel for Rheumatoid Arthritis: Published in Translational Research (2024), this research identifies biomarkers for predicting the response to Tocilizumab in rheumatoid arthritis patients, showcasing her translational bioinformatics skills.
  3. Refinement of Spectral Counting in Quantitative Proteomics: This work, published in Expert Review of Proteomics (2024), addresses limitations in spectral counting and enhances accuracy, reflecting Ara’s commitment to advancing proteomics methodologies.
  4. Neddylation of Insulin Receptor Substrate: Published in Cancer Gene Therapy (2024), this study explores the implications of insulin signaling in cancer cell migration, underlining her interdisciplinary research approach.
  5. TNF-α Modulation in Breast Cancer Cells: Featured in Cancer & Metabolism (2021), this research investigates the differential modulation of mitochondrial complex activity in breast cancer cells, emphasizing her contributions to cancer biology.

🏅Accolades and Recognition :

Ara Cho’s dedication and contributions to the field of proteomics have been recognized through various accolades and invitations to present her research at prestigious conferences. Noteworthy among her conference presentations are:

  1. Transformative Proteomics for Precision Medicine: An oral presentation at KHUPO Virtual Conference, Korea (September 2020), where she discussed the impact of proteomics on precision medicine.
  2. International Conference KSMCB 2020: A poster presentation at KSMCB Virtual Conference, Korea (October 2020), where she showcased her innovative research findings.
  3. 10th Asia-Oceania Human Proteome Organization Congress: An oral presentation in Busan, Korea (June 2021), highlighting her contributions to proteomics.
  4. 71st Conference on Mass Spectrometry and Allied Topics: A poster presentation in Texas, United States (June 2023), demonstrating her international research impact.

Impact and Influence 

Ara Cho’s research has had a profound impact on the field of proteomics and translational bioinformatics. Her work on biomarker discovery and diagnostic strategies has the potential to revolutionize personalized medicine, particularly in the context of autoimmune diseases and cancer. By integrating mass spectrometry with machine learning and bioinformatics, she has contributed to the development of predictive models and diagnostic tools that enhance treatment precision and patient outcomes.

🚀Legacy and Future Contributions :

Ara Cho’s legacy lies in her relentless pursuit of scientific excellence and her contributions to advancing proteomics research. Her innovative approaches and interdisciplinary research have paved the way for future discoveries in biomarker identification and disease diagnostics. As she continues her Ph.D. studies and beyond, Ara is poised to make further significant contributions to the scientific community, driving forward the fields of analytical chemistry, proteomics, and translational bioinformatics.

🎓Publication 

TNF-α differentially modulates subunit levels of respiratory electron transport complexes of ER/PR+ ve/− ve breast cancer cells to regulate mitochondrial complex activity and …

  • Authors   :Anjali Shinde, Hyeryeon Jung, Hayun Lee, Kritarth Singh, Milton Roy, Dhruv Gohel, Han Byeol Kim, Minal Mane, Hitesh Vasiyani, Fatema Currim, Yu Ri Seo, Seojin Yang, Ara Cho, Eugene C Yi, Rajesh Singh
  • Journal    :Cancer & Metabolism
  • Year         : 2021

Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration

    • Authors :Jun Bum Park, Geon Ho Moon, Ara Cho, Minji Kwon, Jong-Wan Park, Eugene C Yi, Haeryoung Kim, Junji Fukuda, Cheol Kwak, Young-Gyu Ko, Yang-Sook Chun
    • Journal   :Cancer Gene Therapy
    • Year       :

A Multi-Biomarker Panel for Predicting Tocilizumab Response in Rheumatoid Arthritis Patients

  • Authors  :, Ara Cho, Jinsung Ahn, Andrew Kim, Yun Jong Lee, Yeong Wook Song, Yoshiya Tanaka, C Yi Eugene
  • Journal    :Translational Research
  • Year         :  2024

Proteomics analysis of an individual formalin‐fixed paraffin‐embedded tissue section using isobaric‐tag amplification

  • Authors  :Ara Cho, Jinsung Ahn, Andrew Kim, Jeong Hyun Lee, Han Suk Ryu, Kristine M Kim, Eugene C Yi
  • Journal   :Rapid Communications in Mass Spectrometry
  • Year        :   2023

 

 

Assist Prof Dr. Ali Tavakoli|Oncology Pharmaceuticals|Best Researcher Award-1234

Published on by Top Pharmaceutical

Assist Prof Dr. Ali Tavakoli,Oncology Pharmaceutical,Best Researcher Award

Assist Prof Dr. Ali Tavakoli, at Shiraz University of Medical Sciences,Iran

PROFILE

GOOLE scholar

🎓Early Academic Pursuits :

Dr. Ali Tavakoli embarked on his distinguished academic journey by earning his Medical Doctor (MD) degree from Shiraz University of Medical Sciences in Shiraz, Iran, in 1998. His early academic pursuits were marked by a profound interest in the complexities of the human body and the desire to contribute to medical science. This foundational phase was not just about acquiring knowledge but also about laying the groundwork for a career dedicated to improving health outcomes.

He continued his academic journey with a Master in Public Health (MPH) from the same institution in 2007. His MPH thesis, which focused on investigating risk factors of low birth weight in newborns, underlined his commitment to addressing public health issues. The meticulous work conducted under the supervision of Dr. Mohammad Hadi Imanieh showcased his analytical skills and dedication to maternal and child health.

🩺Professional Endeavors :

Dr. Tavakoli’s professional career has been a blend of clinical practice, administrative roles, and academic contributions. As an Assistant Professor in the Department of Persian Medicine at Shiraz University of Medical Sciences, he has been instrumental in advancing the field of traditional medicine. His role involves not only teaching but also mentoring students and conducting groundbreaking research.

Between May 2020 and November 2021, he served as the Advisor to the Chancellor of Shiraz University of Medical Sciences, a role that emphasized his leadership and strategic planning abilities. His involvement in significant projects, such as the national food security project in Zarrin Dasht County and the national MMR vaccination project, highlights his dedication to public health initiatives.

📚Contributions and Research Focus :

Dr. Tavakoli’s research has significantly contributed to various fields, including traditional Persian medicine, public health, and clinical trials. His Ph.D. thesis, supervised by Dr. Seyed Alireza Taghavi, evaluated the effect of Rose (Rosa damascena mill L) Oil Soft Capsules on clinical outcomes in ulcerative colitis, showcasing his innovative approach to integrating traditional remedies with modern clinical practices.

His extensive list of publications, including studies on the quality of work life and human resource productivity, the effects of medicinal plants on clinical conditions, and the efficacy of traditional treatments, reflects his diverse research interests and his ability to bridge traditional and modern medicine. Notable publications include:

  • “Efficacy of Rose Oil Soft Capsules on Clinical Outcomes in Ulcerative Colitis: A Pilot Randomized, Double-Blinded, Placebo-Controlled Clinical Trial” (Galen Medical Journal, 2019)
  • “COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study” (Iranian Journal of Medical Sciences, 2023)
  • “Efficacy of Plantago major leaf extract cream in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial” (European Journal of Integrative Medicine, 2023)

🏆Accolades and Recognition :

Dr. Tavakoli’s excellence has been recognized through various awards and honors. He was the top student in the Traditional Persian Medicine Ph.D. comprehensive exam at Shiraz University of Medical Sciences in 2014 and the top Ph.D. graduate in 2012. In 2010, he was awarded as the Annual Best Staff at Shiraz University of Medical Sciences, reflecting his outstanding contributions to the institution.

🌟Impact and Influence :

Dr. Tavakoli has had a profound impact on both his students and the broader medical community. His leadership roles, such as being a member of the Executive Committee of the Shiraz International mHealth Congress and his involvement with the Iranian Scientific Association of Traditional Medicine, have allowed him to influence the direction of medical research and public health policies.

🌍Legacy and Future Contributions :

Dr. Tavakoli’s legacy is characterized by his commitment to integrating traditional Persian medicine with contemporary clinical practices. His work has paved the way for future research in this field, promoting a holistic approach to healthcare. His ongoing research and publications continue to influence and inspire new generations of medical professionals.

In the future, Dr. Tavakoli aims to expand his research into the global applications of traditional Persian medicine, contributing to international medical knowledge and practices. His dedication to education, research, and public health ensures that his contributions will have a lasting impact on the medical community and beyond.

🎓Publication 

Reporting of adverse effects of pomegranate in clinical studies: a systematic review

  • Authors   :Hamid Zare, Ehsan Amiri Ardekani, Ali Tavakoli, Ryan Bradley, Fatemeh Tavakoli, Mehdi Pasalar
  • Journal    :Journal of Complementary and Integrative Medicine
  • Year         : 2024

Radiodermatitis in the field of traditional Persian medicine; a narrative review

    • Authors :Ghazaleh Heydarirad, Bahareh Ahadi, Ali Tavakoli, Hamid Reza Mirzaei, Mojgan Mehri Ardestani, Shaghayegh Kamian, Mehdi Pasalar
    • Journal   :Annals of the Romanian Society for Cell Biology
    • Year       : 2021

World Congress Integrative Medicine & Health 2017: part two: Berlin, Germany. 3–5 May 2017

  • Authors  :, Kyung-Eun Choi, Lisha He, Han Wang, X He, C Gu, Y Zhang, Linhua Zhao, Xiaolin Tong, Lisha He, Han Wang, Xinhui He, Chengjuan Gu, Ying Zhang, Linhua Zhao, Xiaolin Tong, Lisha He
  • Journal    :BMC Complementary and Alternative Medicine
  • Year         :  2017

Efficacy of Plantago major leaf extract cream compared to placebo in preventing acute radiodermatitis in breast cancer patients: A randomized clinical trial

  • Authors  :Zahra Salehi, Ali Tavakoli, Seyed Hassan Hamedi, Soodabeh Samimi, Foroogh Namjooyan, Mansour Ansari, Hamid Nasrollahi, Nezhat Khanjani, Niloofar Ahmadloo, Ahmad Mosalaei, Behnam Kadkhodaei, Hossein Molavi Vardanjani, Mehrab Sayadi
  • Journal   :European Journal of Integrative Medicine
  • Year        :   2023

 

Impact of Jollab on Blood Parameters in Patients with Breast Cancer Undergoing Chemotherapy: A Pilot Randomized Controlled Trial

  • Authors  :Ghazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali TavakoliGhazaleh Heydarirad Ahadi, Bahareh Ahadi, Mehdi Pasalar, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Ali Tavakoli
  • Journal   :Galen Medical Journal
  • Year        :   2021

Prof . Helen Hughes|Drying technologies|Best Researcher Award

Published on by Top Pharmaceutical

Prof . Helen Hughes,Drying technologies,Best Researcher Award

Prof . Helen Hughes, at South East Technological University,Ireland

PROFILE

Orcid

🎓Early Academic Pursuits :

Prof. Helen Hughes began her academic journey with a B.Sc. in Analytical Science from Dublin City University (DCU), graduating with a 2.1 in 1990. She continued her studies at DCU, earning a Ph.D. in 1993. In 1994, she completed a Quality Auditor certification from Shannon Quality Training, further enhancing her expertise in quality management.

💼Professional Endeavors :

Prof. Hughes’s professional career is marked by a series of impactful roles across academia and industry. She started as an Analyst at Squibb-Linson Ltd. and Schering-Plough Ltd., gaining hands-on experience in the pharmaceutical industry. She then served as a Q.A. Manager at Waterford Foods from 1993 to 1994 and a Research Analyst at Gerard Laboratories in 1994. Since 1994, Prof. Hughes has been a dedicated lecturer at Waterford Institute of Technology (WIT), now South East Technological University (SETU). Her teaching portfolio includes courses in Quality Management and Inorganic Chemistry, and she has been actively involved in course development and industry liaison for the BSc (Hons) Pharmaceutical Science program.

🔬Contributions and Research Focus :

Prof. Hughes’s research contributions span various domains, including quality management, molecular imprinted polymers, and drug delivery systems. She has supervised 21 Ph.D. and 2 MSc students to completion and currently mentors seven Ph.D. students. Prof. Hughes has secured over €12 million in competitive research funding and published 52 peer-reviewed articles, a book chapter, and 74 conference proceedings, amassing 2,358 citations and an H-index of 25.

As a founding member of the Pharmaceutical and Molecular Biotechnology Research Centre (PMBRC) and the Eco-Innovation Research Centre (EIRC) at WIT, Prof. Hughes has significantly advanced research in biopharmaceuticals and eco-innovation. Her current research includes leading the (bio)pharmaceutical sub-group for developing the MPharm pharmacy program at SETU and organizing the national environmental conference, Environ 2024.

🏅Accolades and Recognition :

Prof. Hughes’s excellence in research and education has been recognized through various awards and honors. She received the WIT annual award for excellence in postgraduate research supervision in 2009. Additionally, she has served as an expert reviewer for high-impact journals and funding agencies and participated in national panels, such as the review of all IRCSET applications in 2012. Her course leadership of the BSc (Hons) Pharmaceutical Science program earned the Pharma Industry Education and Training awards in 2017 and 2022.

🌍Impact and Influence :

Prof. Hughes’s influence extends beyond her research and teaching. She has collaborated extensively with national and international organizations, contributing to industry and academia. Her leadership roles in professional bodies, such as EURACHEM and Excellence Ireland, highlight her commitment to advancing analytical measurement and quality management. Prof. Hughes has also played a pivotal role in mentoring and guiding postgraduate students and staff, fostering a collaborative research environment.

🌟Legacy and Future Contributions :

Prof. Hughes’s legacy is marked by her dedication to research, education, and community engagement. She has left an indelible mark on the academic and scientific communities through her extensive research funding, publications, and student mentorship. Her future contributions are expected to continue influencing the fields of pharmaceutical science and eco-innovation, driven by her ongoing research and leadership in program development.

 

🎓Publication 

Phosphate removal from wastewater using scallop and whelk shells

  • Authors   :Egbedi Brakemi; Kinsella Michael; Shiau Pin Tan; Hughes Helen
  • Journal    :Water Process Engineering
  • Year         : 2023

Evaluation and Screening of Biopharmaceuticals using Multi-Angle Dynamic Light Scattering

    • Authors :Jason Beirne; Dikshitkumar Khamar; Ciaran Maguire; Ambrose Hayden; Helen Hughes
    • Journal   :PharmSciTech
    • Year       : 2023

Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan

  • Authors  :Niall J. O’Reilly; Anuj Chauhan; Laurence Fitzhenry; Helen Hughesf
  • Journal    :Pharmaceutics
  • Year         :  2021

Penetration Enhancers for Topical Drug Delivery to the Ocular Posterior Segment—A Systematic Review

  • Authors  :Abhinav Thareja; Helen Hughes; Carmen Alvarez-Lorenzo; Jenni J. Hakkarainen; Zubair Ahmed
  • Journal   :Pharmaceutics
  • Year        :   2021

 

Dissolving microneedle based transdermal delivery of therapeutic peptide analogues

  • Authors  :Hughes, H.; O’Reilly, N.J.; Allender, C.J.; Barrow, D.A.; McLoughlin, P.
  • Journal   :pharmaceutics
  • Year        :   2019

Mr. Mahmoud Mansour| Drug analysis|Best Researcher Award

Published on by Top Pharmaceutical

Mr. Mahmoud Mansour,Drug analysis,Best Researcher Award

Mr. Mahmoud Mansour, at King Saud bin Abdulaziz University for health Sciences,saudi Arabia

PROFILE

Google scholar
Scopus

🎓Education :

  • PhD in Biochemistry (Leukotrienes and Lipoxins: Bioactive Mediators)
    • Institution: Karolinska Institutet, Stockholm, Sweden
    • Years: 1990-1993
    • Thesis: Role of Leukotrienes C4 and B4 in chronic myeloid leukemia: Specificity of interaction with GM-CSF
  • Master’s Degree in Biochemistry
    • Institution: Al-Azhar University, Cairo, Egypt
    • Years: 1987-1990
    • Thesis: Female sex steroids and peptide hormones in breast cancer in relation to estrogen receptor
  • Diploma in Biochemical Analysis
    • Institution: Al-Azhar University, Cairo, Egypt
    • Years: 1985-1986
    • Grade: Very Good
  • Bachelor of Pharmaceutical Sciences
    • Institution: Al-Azhar University, Cairo, Egypt
    • Years: 1978-1984
    • Grade: Excellent with Honors

🏅Management Experience :

  • Head, Tumor Markers Oncology Research Unit
    • Department: Biochemistry, Al-Azhar University
    • Years: 09/2002 – 08/2005

🏆 Honors & Awards :

  • Travel Award to the International Pharmaceutical Students Federation Conference, Lausanne, Switzerland (1983)
  • State Encouragement Award in Medical Sciences (1998)

🔬 Research Interests :

  • Leukotrienes and lipoxins, oxidative damage, tumor markers, molecular biology, and cancer treatment methodologies.

 

🎓Publication 

Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT‐diaphorase in different tissues of mice: a possible mechanism of action

  • Authors   :Mahmoud A Mansour, Mahmoud N Nagi, Aiman S El‐Khatib, Abdullah M Al‐Bekairi
  • Journal    :Cell biochemistry and function
  • Year         : 2002

Protective effect of thymoquinone against doxorubicin–induced cardiotoxicity in rats: A possible mechanism of protection

    • Authors :Mahmoud N Nagi, Mahmoud A Mansour
    • Journal   :Pharmacological research
    • Year       : 2000

Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone

  • Authors  :Mahmoud Ahmed Mansour, OT Ginawi, T El-Hadiyah, AS El-Khatib, OA Al-Shabanah, HA Al-Sawaf
  • Journal    :Research communications in molecular pathology and pharmacology,
  • Year         :  2001

Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice

  • Authors  :Mahmoud A Mansour
  • Journal   :Life sciences
  • Year        :   2000

 

Inhibition of 5-lipoxygenase and Leukotriene C4 Synthase in Human Blood Cells by Thymoquinone

  • Authors  :Mahmoud Mansour, Susanne Tornhamre
  • Journal   :enzyme inhibition and medicinal chemistry
  • Year        :   2004

Assist Prof Dr. Ahmed Srag el-din| Nanotechnology|Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr. Ahmed Srag el-din,Nanotechnology,Best Researcher Award

Assist Prof Dr. Ahmed Srag el-din, at Delta university for science and technology,Egypt

PROFILE

Orcid
Scopus

Early Academic Pursuits 🎓

Dr. Ahmed SG Srag El-Din embarked on his academic journey with a focus on pharmaceutical sciences. His early academic pursuits were marked by a deep interest in drug delivery systems and nanotechnology. He began his higher education with a Bachelor’s degree in Pharmacy, where he developed a strong foundation in pharmaceutical sciences. Driven by a passion for research and innovation, he pursued advanced degrees, leading to a robust understanding of drug formulation and delivery mechanisms. This academic groundwork set the stage for his future contributions to the field.

Professional Endeavors 🏆

Dr. El-Din’s professional career has been characterized by a commitment to advancing pharmaceutical science and drug delivery technologies. He has held various positions that allowed him to leverage his expertise in pharmaceutical research and development. His professional trajectory includes roles in academia, where he has been involved in teaching and mentoring the next generation of pharmaceutical scientists. His work has not only contributed to the academic community but also to practical applications in drug delivery systems.

Contributions and Research Focus 🔬

Dr. El-Din’s research has significantly impacted the field of pharmaceutical sciences, particularly in the development and evaluation of novel drug delivery systems. His contributions include:

  1. Self-Nanoemulsifying Drug Delivery Systems: He has developed and evaluated self-nanoemulsifying drug delivery systems for sinapic acid, enhancing its antiviral efficacy against SARS-CoV2. This research has potential implications for the treatment of viral infections, demonstrating his innovative approach to drug delivery.
  2. Nanoparticle-Based Drug Delivery: His work on azithromycin-loaded chitosan nanoparticles and starch nanoparticles for enhancing oral bioavailability of drugs highlights his focus on improving drug delivery efficiency and therapeutic outcomes.
  3. Transdermal Delivery Systems: Dr. El-Din has explored novel transdermal delivery systems, including thermosensitive gels and nanoethosomal gels, to improve the absorption and efficacy of medications such as betahistine dihydrochloride.
  4. Antitumor and Anticancer Therapeutics: His research includes the optimization of PLGA nanoparticles for delivering novel anticancer peptides and the development of particulate delivery systems for antitumor therapeutics.

Accolades and Recognition 🏅

Dr. El-Din has been recognized for his contributions to pharmaceutical research through various accolades and honors. His work has been published in reputable journals, including:

  • Pharmaceutics: A prominent paper on self-nanoemulsifying drug delivery systems for sinapic acid.
  • Drug Design, Development and Therapy: Notable for research on starch nanoparticles and their pharmaceutical applications.
  • Journal of Drug Delivery Science and Technology: Published a significant study on selenium nanoparticles and their therapeutic potential.

These publications reflect his commitment to advancing pharmaceutical science and his recognition as a leading researcher in the field.

Impact and Influence 🌟

Dr. El-Din’s research has had a substantial impact on both academic and practical aspects of pharmaceutical science. His work on novel drug delivery systems has influenced the development of more effective and efficient therapeutic formulations. The innovative approaches he has introduced in drug delivery technologies have potential applications in various therapeutic areas, including antiviral treatments, cancer therapy, and transdermal drug delivery.

His influence extends to the academic community through his role in teaching and mentoring students, contributing to the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🔮

Dr. El-Din’s legacy in pharmaceutical science is marked by his pioneering research and contributions to drug delivery systems. His innovative work has laid the groundwork for future advancements in the field, and his research continues to inspire new approaches to drug formulation and delivery.

🎓Publication 

Selenium nanoparticle ameliorates LPS-induced acute lung injury in rats through inhibition of ferroptosis, inflammation, and HSPs

Development and Evaluation of a Self-Nanoemulsifying Drug Delivery System for Sinapic Acid with Improved Antiviral Efficacy against SARS-CoV-2

    • Authors :Alhadrami, H.A., El-Din, A.S.G.S., Hassan, H.M., … Rateb, M.E., Naguib, D.M.
    • Journal   :Pharmaceutics
    • Year       : 2023

Physicochemical characterization of novel particulate delivery systems for antitumor/metastatic therapeutics

Starch nanoparticles preparation and characterization by in situ combination of sono-precipitation and alkali hydrolysis under ambient temperature

  • Authors  :Gardouh, A.R., El-Din, A.S.G.S., Mostafa, Y., Gad, S.
  • Journal   :Pharmacy and Technology
  • Year        :   2021

 

Optimization of plga nanoparticles for delivery of novel anticancer ck-10 peptide

  • Authors  :Samuel, G., Nazim, U., El-Din, A.S.G.S.
  • Journal   :pharmacy and Technology
  • Year        :   2021

Prof Dr. Mohamed Attia shafie|Formulation Science| Innovator in Pharmaceutical Research Award

Published on by Top Pharmaceutical

Prof Dr. Mohamed Attia shafie,Formulation Science,Innovator in Pharmaceutical Research Award

Prof Dr. Mohamed Attia shafie, at Faculty of Pharmacy,Egypt

PROFILE

Orcid
Scopus

 

🎓Early Academic Pursuits :

Professor Mohamed Attia Shafie began his academic journey at Assiut University, Egypt, where he pursued his Bachelor’s degree in Pharmacy and Pharmaceutical Chemistry, graduating in 1969. His interest in the field propelled him to further his education at the same institution, where he obtained a Master’s degree in Pharmaceutics in 1972. His research focused on the interactions between plastic containers and certain liquid pharmaceutical preparations, highlighting his early engagement with the critical aspects of pharmaceutical formulation.

In pursuit of deeper knowledge and expertise, Professor Attia Shafie moved to the First Medical Institute in Moscow, USSR, to complete his Ph.D. in 1978. His doctoral research on the formulation of ophthalmic preparations included extensive studies on the physico-chemical properties and pharmacokinetics of an ophthalmic ointment containing sulfapyridine and hydrocortisone acetate. This foundation set the stage for his future contributions to the field of pharmaceutics.

🏫Professional Endeavors :

Professor Attia Shafie’s professional career spans several decades, primarily focused on teaching and research in the field of pharmaceutics. He has held numerous esteemed positions at various academic institutions. Currently, he is a Professor of Pharmaceutics at the Faculty of Pharmacy, Assiut University, where he has been teaching since 2011. He is responsible for imparting knowledge on topical preparations to students and has made significant contributions to curriculum development.

Before his current role, he served as the Head of the Pharmaceutical Technology Department at the German University in Cairo from 2006 to 2011, where he taught quality assurance and current good manufacturing practices (cGMP). His leadership extended to Assiut University, where he was the Professor and Head of the Pharmaceutics Department from 2002 to 2006, teaching courses in biopharmaceutics and dosage form design.

In addition to his academic roles, Professor Attia has garnered experience in the pharmaceutical industry. He worked as a consultant for Liptis Pharmaceuticals and Cid Pharmaceutical Company, where he contributed to product development and quality control from 2004 to 2006. He also served as a Production Manager at T3A Pharmaceutical Company from 1999 to 2000, managing the production of various pharmaceutical dosage forms.

🔬Contributions and Research Focus :

Throughout his career, Professor Attia Shafie has made substantial contributions to pharmaceutical sciences, particularly in the areas of ophthalmic preparations, buccal delivery, and the oral delivery of proteins and peptides. His research has led to the development of innovative formulations, including prednisolone-loaded cationic nanoemulsions for uveitis management, and Sertaconazole-PLGA nanoparticles for managing ocular keratitis.

His publication record is extensive, with numerous articles in reputable journals such as the Journal of Drug Delivery Science and Technology and Pharmaceutics. His work on chitosan nanoparticles for ocular delivery and the formulation of topical delivery systems for fungal infections highlights his commitment to advancing drug delivery technologies.

🏆Accolades and Recognition :

Professor Attia Shafie’s contributions to the field have been widely recognized. His research has not only advanced the understanding of drug delivery systems but has also significantly influenced clinical practices in ophthalmology. His published works are frequently cited, reflecting his impact on both academia and the pharmaceutical industry. His ability to bridge the gap between theoretical research and practical application has earned him a reputation as a leading expert in pharmaceutics.

🌍Impact and Influence :

Professor Attia Shafie’s impact extends beyond research and teaching; he has influenced a generation of pharmacy students and professionals. His emphasis on quality assurance and formulation design has shaped the curricula of various pharmacy programs. By mentoring students and guiding them through their academic journeys, he has fostered a new generation of pharmacists and researchers who are well-equipped to tackle future challenges in the pharmaceutical field.

His work has also contributed to the development of safer and more effective pharmaceutical products, thereby enhancing patient care and outcomes. Through collaborations with pharmaceutical companies, he has facilitated the translation of research findings into practical solutions that address real-world health issues.

 

🎓Publication 

Sertaconazole-PLGA nanoparticles for management of ocular keratitis

Prednisolone loaded-cationic nanoemulsion formulation for uveitis management

Permeation-Enhancing Nanoparticle Formulation to Enable Oral Absorption of Enoxaparin

High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes

 

Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells

Prof. Cedrick MUTOMBO SHAKALENGA |Medicinal Chemistry| Best Researcher Award

Published on by Top Pharmaceutical

Prof. Cedrick MUTOMBO SHAKALENGA,Medicinal Chemistry,Best Researcher Award

Prof. Cedrick MUTOMBO SHAKALENGA, at University of Lubumbashi,Democratic Republic Congo

PROFILE

Orcid

Scopus

Google scholar

📚Early Academic Pursuits :

Cedrick Mutombo Shakalenga was born on February 26, 1991, in Manono, a town located in the Democratic Republic of Congo. His academic journey began in Mukushi / Manono Primary School, where he obtained his Primary School Certificate in 2003. Cedrick then pursued secondary education at the Bunyinge / Manono Institute, earning a State Diploma in General Pedagogy in 2009. His passion for pharmaceutical sciences led him to enroll at the University of Lubumbashi, where he completed a Pharmacist Diploma with a specialization in Hospital & Community Pharmacy in 2016.

🏢Professional Endeavors :

Cedrick’s professional career is marked by significant milestones and diverse roles within the pharmaceutical field. His early work experience includes teaching at Maendeleo/Lusa Primary School in Manono from 2009 to 2010 and serving as a Pharmacist at the Tamtam Pharmacy in Lubumbashi during 2014-2015. His academic career took off when he joined the University of Lubumbashi’s Faculty of Pharmaceutical Sciences as a Teaching Assistant from 2018 to 2022.

In 2023, Cedrick was promoted to Associate Professor at the same institution, where he now lectures on Biophysics I and II and Traditional Medicine. Additionally, he has contributed significantly to the scientific community through his role as a Scientific Research Officer at the “Jardin d’Etude Pharmaceutiques” club.

🔬Contributions and Research Focus :

Cedrick’s research is centered on integrating traditional medicine into the official health system of DR Congo. His Ph.D. thesis, titled “Conditions for the Integration of Traditional Medicine into the Official Health System in DR Congo, Case of Lubumbashi city,” reflects his dedication to this cause. He has co-authored several influential publications that explore various aspects of traditional medicine, pharmacognosy, and public health. His research not only highlights the socio-economic importance of medicinal plants but also addresses public health challenges in DR Congo.

 

🏅Accolades and Recognition :

Cedrick’s dedication and contributions to the field of pharmaceutical sciences have been widely recognized. In 2023, he received the prestigious “Peter Hylands award” for his poster presentation at the 11th Annual Meeting of The Good Practice in Traditional Chinese Medicine Research Association (GP-TCM RA). His research on the authentication of Securidaca longepedunculata Fresen., a highly sought-after medicinal plant, earned him this accolade.

🌍Impact and Influence :

Cedrick’s work has had a profound impact on the field of traditional medicine in DR Congo. His efforts to integrate traditional practices into the formal health system have the potential to improve healthcare accessibility and affordability for many Congolese citizens. By advocating for the scientific validation and quality control of traditional medicines, Cedrick is helping to bridge the gap between traditional and modern medical practices.

🚀Legacy and Future Contributions :

Cedrick Mutombo Shakalenga’s legacy lies in his unwavering commitment to enhancing the pharmaceutical landscape in DR Congo. His pioneering research and advocacy for traditional medicine integration have set a foundation for future advancements in the field. As an Associate Professor, he continues to inspire and mentor the next generation of pharmaceutical scientists, ensuring that his impact will resonate for years to come.

📝Conclusion :

Cedrick Mutombo Shakalenga’s journey from a small town in Manono to becoming an influential figure in pharmaceutical sciences is a testament to his dedication, hard work, and visionary approach. His contributions to traditional medicine, his extensive research portfolio, and his role as an educator highlight his multifaceted impact on the scientific community and society at large. Cedrick’s ongoing efforts and future endeavors promise to further advance the integration of traditional and modern medicine, ultimately improving healthcare outcomes in DR Congo and beyond.

🎓Publication 

Quality control of herbal drugs and preparations: The methods of analysis, their relevance and applications

  • Authors   :N.W Muyumba, S.C Mutombo, H Sheridan, A Nachtergael, Duez P
  • Journal    :Talanta Open
  • Year         : 2021

Perceptions and use of traditional African medicine in Lubumbashi, Haut-Katanga province (DR Congo): A cross-sectional study

    • Authors :SC Mutombo, AS Bakari, NV Ntabaza, A Nachtergael, SJB Lumbu, P Duez, BJ Kahumba
    • Journal   :PLoS ONE
    • Year       : 2022

Knowledge, attitudes and practices among the population, towards COVID-19 in the Lubumbashi city (DR Congo): An online cross-sectional survey

  • Authors  :MH Manya, SC Mutombo, CV Bashige, Nzuzi MG, TA Kabamba, MA Mutombo, MC Kibwe, MO Moke, JC Nkwanga, NT Nsumbu, AS Bakari, BJ Kahumba, SJB Lumbu
  • Journal    :World Journal of Biology Pharmacy and Health Sciences
  • Year         :  2021

Knowledge, attitude, and practice towards hepatitis B and C viruses among the population of Lubumbashi, Democratic Republic of Congo

  • Authors  :TA Kabamba, MH Manya, SC Mutombo, BC Kasongo, CKC Kakisingi, KS Matanda, MA Mutombo, MC Mwamba, NA Ngulu, MB Kabamba, OA Longanga
  • Journal   :African Journal of Gastroenterology and Hepatology
  • Year        :   2023

 

Mineral elements analysis and total flavonoids content in the fresh leaves from two varieties of Hibiscus sabdariffa L. consumed as vegetable in Lubumbashi (DR Congo)

  • Authors  :Shakalenga Cedrick Mutombo, Mboni Henry Manya, Nkulu Salvator Nsenga, Mavungu Gaël Nzuzi, Mwenya Cynthia Kibwe, Mwinensenge James Maloba, Chiribagula Valentin Bashige, Amuri Salvius Bakari, Byanga Joh Kahumba, Badibanga Bualufu Victor Ndibualonji
  • Journal   :World Journal of Advanced Research and Reviews
  • Year        :   2021

Assist Prof Dr. Maryam Rangchian|Herbal Medicine| Best Researcher Award-1235

Published on by Top Pharmaceutical

Assist Prof Dr. Maryam Rangchian ,Herbal Medicine,Best Researcher Award

Assist Prof Dr. Maryam Rangchian , at Pharmacy School of Hamadan University of Medical Sciences,Iraq

PROFILE

Orcid

Early Academic Pursuits 📚

Maryam Rangchian’s journey in the field of pharmacy began with a solid foundation in her early academic years. She excelled in her studies, securing the third national position in the Basic Science Exam in 2002. This early achievement was a testament to her dedication and intellectual prowess. Maryam pursued her Pharm.D. at Shahid Beheshti University of Medical Sciences in Tehran, where she continued to distinguish herself. She was recognized as the Excellent Student of Pharmacy School in 2008, a recognition that highlighted her commitment and exceptional performance in her studies. This period laid the groundwork for her future endeavors in the field of pharmacoeconomics and pharma management.

💼Professional Endeavors :

Maryam Rangchian’s professional journey is marked by significant contributions and leadership roles in academia and industry. As an Assistant Professor at the Pharmacy School of Hamadan University of Medical Sciences, she has been instrumental in shaping the future of pharmacy education. Her role as the Director of the Office of Industry and Society Relations further underscores her commitment to bridging the gap between academia and industry. Maryam’s expertise in pharmacoeconomics and pharma management is reflected in her consultancy work, where she has successfully led five industry projects, demonstrating her ability to apply academic knowledge to practical, real-world challenges.

🔬Contributions and Research Focus :

Maryam’s research focuses on critical areas such as pharmaceutical care, the market for pharmaceutical and personal care products, and the social responsibility of institutions and individuals in the pharmaceutical sector. She has completed or is currently engaged in 33 research projects, showcasing her prolific research activity. Her work has been widely recognized, with 23 publications in journals indexed by Scopus and other scientific databases. Maryam’s research is not just about numbers; it has a real impact on improving medication processes. The interventions she has suggested have been well-received by patients and have provided valuable insights for enhancing pharmaceutical practices.

🏆Accolades and Recognition :

Maryam Rangchian’s contributions to the field have not gone unnoticed. She has received several prestigious honors, including being named the Hamadan Exemplar Pharmacist in 2023. Her academic excellence was recognized early on, as she was awarded the title of Excellent Student in the Pharmacoeconomics and Pharma Management Department in 2015 at Shahid Beheshti University of Medical Sciences. Maryam also achieved first place in the comprehensive exam in the field of pharmacoeconomics and pharma management. These accolades reflect her dedication, hard work, and outstanding contributions to the field of pharmacy.

🌍Impact and Influence :

Maryam’s work has had a significant impact on both the academic community and the pharmaceutical industry. Her research findings have contributed to the development of better medication processes, benefiting patients and healthcare providers alike. As an invited reviewer for numerous prestigious journals, including BMC Health Services Research, BMC Medical Education, and BMJ Open, she has played a crucial role in shaping the quality of research in her field. Her active involvement in professional associations, such as the Iranian Association of Pharma Management and Economics and the International Society of Pharmacoeconomics and Outcome Research, further amplifies her influence and commitment to advancing her field.

🌟Legacy and Future Contributions :

Looking ahead, Maryam Rangchian is poised to continue her impactful work in pharmacoeconomics and pharma management. Her legacy is one of academic excellence, professional dedication, and meaningful contributions to healthcare. She is committed to furthering research that addresses the evolving challenges in the pharmaceutical industry, focusing on areas such as pharmaceutical care, market dynamics, and social responsibility. Maryam’s future contributions will undoubtedly build on her strong foundation, driving innovation and improving healthcare outcomes.

🎓Publication 

Performance model of community pharmacies in low-middle income countries: A societal perspective

  • Authors   :Ranghchian, M.; Sehat, S.; Akhgari, M.; Mehralian, G.r
  • Journal    :Retailing and Consumer Services
  • Year         : 2018

Underlying factors influencing community pharmacies business in low- to medium-developed markets: A societal perspective

    • Authors :Rangchian, M.; Mehralian, G.; Salamzadeh, J.; Vatanpour, H
    • Journal   :Pharmaceutical Health Services Research
    • Year       : 2016

Pharmaceutical care in a community-based practice setting in Iran: Current status and future challenges

  • Authors  :Mehralian, G.; Rangchian, M.; Afsharmanesh, G.; Seifi, N.
  • Journal    :Pharmaceutical Health Services Research
  • Year         :  2015

Client priorities and satisfaction with community pharmacies: The situation in Tehran

  • Authors  :Mehralian, G.; Rangchian, M.; Rasekh, H.R.
  • Journal   :Clinical Pharmacy
  • Year        :   2014

 

Investigation on barriers to pharmaceutical care in community pharmacies: a structural equation model

  • Authors  :Mehralian, G.; Rangchian, M.; Javadi, A.; Peiravian, F.
  • Journal   :Clinical Pharmacy
  • Year        :   2014